T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation-Reference-Cited by-同舟云学术

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation

Published:2003-12-27 Issue:12 Volume:76 Page:1705-1713
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Baron Frédéric,Schaaf-Lafontaine Nicole,Humblet-Baron Stéphanie,Meuris Nathalie,Castermans Emilie,Baudoux Etienne,Frère Pascale,Bours Vincent,Fillet Georges,Beguin Yves

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference30 articles.

1. Allogeneic hematopoietic stem cell transplantation: yesterday, today, and tomorrow;Storb;Exp Hematol,2003

2. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia;Kolb;Blood,1995

3. Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation;Baron;Transfusion,2000

4. Nonmyeloablative allogeneic hematopoietic stem cell transplantation;Baron;J Hematother Stem Cell Res,2002

5. Mixed chimerism: preclinical studies and clinical applications;McSweeney;Biol Blood Marrow Transplant,1999

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-cell Depletion to Prevent Graft-versus-Host Disease;Thomas’ Hematopoietic Cell Transplantation;2016-01-01

2. Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation;Expert Opinion on Emerging Drugs;2013-05-10

3. Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning;PLoS ONE;2013-02-21

4. Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative conditioning regimens;Transplant Infectious Disease;2012-09-24

5. Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age;Haematologica;2010-10-07